SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25 | -21.9% | 207 | -26.3% | 0.00% | – |
| Q2 2023 | $32 | +6.7% | 281 | +28.9% | 0.00% | – |
| Q1 2023 | $30 | +57.9% | 218 | +51.4% | 0.00% | – |
| Q4 2022 | $19 | -99.8% | 144 | +61.8% | 0.00% | – |
| Q3 2022 | $10,000 | +233.3% | 89 | +134.2% | 0.00% | – |
| Q2 2022 | $3,000 | -66.7% | 38 | -67.8% | 0.00% | – |
| Q1 2022 | $9,000 | +28.6% | 118 | +45.7% | 0.00% | – |
| Q4 2021 | $7,000 | +600.0% | 81 | +406.2% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 16 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 16 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 16 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 16 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 16 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 16 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 16 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 16 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 16 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | -66.7% | 16 | -30.4% | 0.00% | – |
| Q4 2018 | $3,000 | – | 23 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |